Medicaid costs rise with late-stage cancer, study links Medicaid claims to cancer stage and spending patterns, affecting healthcare access.
Closing the women's health gap with a $20 billion federal investment in women's health research and care.
Adding high-dose vitamin d3 chemotherapy failed to improve progression-free survival for metastatic colorectal cancer patients in the SOLARIS trial.
Understanding lymphoma trial results and progression-free survival data for better treatment decisions and quality of life.
Interstitial lung disease diagnosis is often delayed due to overlapping symptoms with asthma and heart failure, requiring physicians to spot subtle clues…
Retatrutide access opens as Eli Lilly launches a compassionate‑use program for patients unable to join clinical trials, awaiting FDA approval soon.
Oncologists face insurance delays and logistical hurdles blocking access to advanced cancer treatments like CAR T-cell therapy.
The multiple myeloma trial reveals an 89% lower risk of disease progression or death with the teclistamab‑talquetamab combo, offering new hope for…
Patients with MASLD or MASH face higher risks of mild cognitive impairment. Learn about the latest study linking liver disease to cognitive…
Wildfire smoke asthma risk rises as dense plumes degrade air quality across the Pacific Northwest, prompting emergency health guidance for sufferers and…